Tai, Y., Chow, A., Han, S., Coker, C., Ma, W., Gu, Y., Estrada Navarro, V., Kandpal, M., Hibshoosh, H., Kalinsky, K., Manova-Todorova, K., Safonov, A., Walsh, E. M., Robson, M., Norton, L., Baer, R., Merghoub, T., Biswas, A. K., & Acharyya, S. (2024). FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer. EMBO Molecular Medicine, 16(8), 1957–1980. https://doi.org/10.1038/s44321-024-00094-2

Kong, Y., Liu, P., Li, Y., Nolan, N. D., Quinn, P. M. J., Hsu, C., Jenny, L. A., Zhao, J., Cui, X., Chang, Y., Wert, K. J., Sparrow, J. R., Wang, N., & Tsang, S. H. (2023). HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy. EMBO Molecular Medicine, 15(2). Portico. https://doi.org/10.15252/emmm.202216525

Kakhlon, O., Vaknin, H., Mishra, K., D’Souza, J., Marisat, M., Sprecher, U., Wald‐Altman, S., Dukhovny, A., Raviv, Y., Da’adoosh, B., Engel, H., Benhamron, S., Nitzan, K., Sweetat, S., Permyakova, A., Mordechai, A., Akman, H. O., Rosenmann, H., Lossos, A., … Weil, M. (2021). Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism. EMBO Molecular Medicine, 13(10). Portico. https://doi.org/10.15252/emmm.202114554